| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/21/2007 | US20070142294 Identification and cloning of novel human gene, RET16, involved in the intracellular signaling cascade |
| 06/21/2007 | US20070141677 Genetic immunization with cationic lipids |
| 06/21/2007 | US20070141620 Producing polyoxyethylene glycol covalently bound to human interferon; antiinflammatory and antitumor agents; autoimmune diseases and infections; conjugation decreases the number of doses for an intended effect, simplify and stabilize the formulation of a composition |
| 06/21/2007 | US20070141058 Method of correcting immunopathological reactions and a medicament |
| 06/21/2007 | US20070141039 Bifidobacterium longum infantis strain secretes a factor that antagonizes the activity ofpro-inflammatory cytokine selected from TNF- alpha, IL-8, IFN gamma to treat inflammatory bowel disease or irritable bowel syndrome |
| 06/21/2007 | US20070141033 Purging of cells using viruses |
| 06/21/2007 | US20070140984 Functional powdery product |
| 06/21/2007 | CA2636139A1 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 06/21/2007 | CA2633374A1 Amine compound and use thereof for medical purposes |
| 06/21/2007 | CA2632466A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 06/21/2007 | CA2632024A1 Treatment of multiple sclerosis using interferon-tau |
| 06/21/2007 | CA2631051A1 Organic compounds |
| 06/21/2007 | CA2571886A1 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 06/20/2007 | EP1798232A1 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 06/20/2007 | EP1798226A1 Triazole derivative |
| 06/20/2007 | EP1797896A1 Adjuvant systems and vaccines |
| 06/20/2007 | EP1797886A2 Immune stimulation using chemically modified RNA |
| 06/20/2007 | EP1797171A1 Methods for the generation of hepatocyte-like cells from human blastocyst-derived stem (hbs) |
| 06/20/2007 | EP1797126A1 Compositions monovalent for cd40l binding and methods of use |
| 06/20/2007 | EP1797044A2 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 06/20/2007 | EP1797043A1 4-(phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists |
| 06/20/2007 | EP1797036A1 Sigma receptor ligands |
| 06/20/2007 | EP1796713A1 Use of gilz protein expressed in dendritic cells to modulate an antigen-specific immune response |
| 06/20/2007 | EP1796699A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 06/20/2007 | EP1796697A1 A composition having immunoregulating activities comprising lactobacillus pentosus |
| 06/20/2007 | EP1796695A2 Pharmaceuticals agents comprising blood components <10 kda and their use for prophylaxis and treatment of defects of the immune system |
| 06/20/2007 | EP1796674A2 5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated kv1.3 potassium channel |
| 06/20/2007 | EP1663966B1 1,3-disubstituted azetidine derivatives for use as ccr-3 receptor antagonists in the treatment of inflammatory and allergic diseases |
| 06/20/2007 | EP1534256A4 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/20/2007 | EP1383762B1 Tetrahydropyridyl-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same |
| 06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1137439B1 Stabilization of rapamycins or derivatives of rapamycins |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | CN1984906A Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity |
| 06/20/2007 | CN1984887A Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 06/20/2007 | CN1984674A Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides |
| 06/20/2007 | CN1984672A Modulation of NKG2D |
| 06/20/2007 | CN1984665A Composition having immunoregulating activities |
| 06/20/2007 | CN1984643A Method and composition for treating rhinitis |
| 06/20/2007 | CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor |
| 06/20/2007 | CN1982331A Recombinant thymus pentapeptide structural analogs, its production and use |
| 06/20/2007 | CN1982329A Biologically active peptide comprising tyrosyl-seryl-valine (YSV) and use thereof |
| 06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/20/2007 | CN1981886A Nasal delivery devices |
| 06/20/2007 | CN1981873A Method of manufacturing micro colloidal particle and use of the same |
| 06/20/2007 | CN1981869A Compound non-carrier antibacterial eye drops containing practofren and its production |
| 06/20/2007 | CN1981850A Health products with life prolonging function and its production |
| 06/20/2007 | CN1981845A Chinese-medicinal composition, its production and use |
| 06/20/2007 | CN1981783A Nano-bee productf for adjusting immune function and its production |
| 06/20/2007 | CN1981778A Medicinal composition for self-immune diseases and organ transplantation exclusion |
| 06/20/2007 | CN1981773A Medicinal preparation for treating immune related diseases |
| 06/20/2007 | CN1981769A Hydrochloride epinastine dispersing tablets and their production |
| 06/20/2007 | CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases |
| 06/20/2007 | CN1981750A Soluble A-SH CoA-SH Q10 composition and its production |
| 06/20/2007 | CN1981645A Black rice and jujube beverage and its production |
| 06/20/2007 | CN1322014C Gecko polysaccharide, and its preparing method and pharmaceutical use |
| 06/20/2007 | CN1322005C Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321693C Over-expressing homologous antigen vaccine and method of making same |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/20/2007 | CN1321685C Peptidoglycan immunopotentiator and its production process |
| 06/20/2007 | CN1321682C New dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |
| 06/20/2007 | CN1321669C Chinese herbal medicine for treating urticaria |
| 06/20/2007 | CN1321666C Combination of medication of containing astragalus root and dragon's blood resin and application |
| 06/20/2007 | CN1321644C Process for making substituted pyrazoles |
| 06/20/2007 | CN1321641C Method for treating allergies using substituted pyrazoles |
| 06/20/2007 | CN1321588C Method for preparing effervescence tablet containing buckwheat, fruit and vegetable |
| 06/19/2007 | US7232909 Pyridine derivatives |
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232838 2-amino-4,5-trisubstituted thiazolyl derivatives |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/14/2007 | WO2007066200A2 Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 06/14/2007 | WO2007065927A1 Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| 06/14/2007 | WO2007065633A1 Modulation of the immune response by administration of intralymphatic transduction allergen (itag) -molecules |
| 06/14/2007 | WO2007065374A1 Use of apricot bark and extracts thereof in manufacturing medicaments for promoting immunity |
| 06/14/2007 | WO2007050375A3 Piperazine derivatives useful as ccr5 antagonists |
| 06/14/2007 | WO2007048847A3 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases |
| 06/14/2007 | WO2007044050A3 1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 06/14/2007 | WO2007040840A3 Aminodiazepines as toll-like receptor modulators |
| 06/14/2007 | WO2007034210A3 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 06/14/2007 | WO2007028047A3 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 06/14/2007 | WO2006124699A3 Blockade of pin1 prevents cytokine production by activated immune cells |
| 06/14/2007 | US20070136896 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 06/14/2007 | US20070135458 6-Substituted pyrido-pyrimidines |
| 06/14/2007 | US20070135414 Tachykinin Antagonists |
| 06/14/2007 | US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134275 Medicaments for the immunotherapy of malignant tumors |
| 06/14/2007 | US20070134268 Vaccines |
| 06/14/2007 | US20070134241 Humanized anti-CD3 specific antibodies |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134187 Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders |